Home •Blog
TTMS Blog
TTMS experts about the IT world, the latest technologies and the solutions we implement.
Sort by topics
Search results for the term: “TEAMS”
Microsoft Teams raises the bar
With their subsequent activities, the creators of Teams consistently confirm that remote work – and ultimately hybrid work – is not a replacement model or a temporary fashion. It is a space taken seriously by Microsoft, to which it is worth delivering technological investments both at the code and hardware level.
Read
MS Teams dynamic view
We wrote about the tendency to “humanize” remote work last year (see article here). In March 2021, the MS Teams platform will follow this trend, presenting its new, more interactive version. Dynamic view – this is the name of the new interface after “tuning”.
Read
Salesforce and Teams integration – cooperation or competition?
#Teams and #salesforce tags in one post? It is fully justified, because from today Salesforce functions as an application, integrated with the Microsoft Teams platform, although both parties still cautiously call it “pilot”. It’s hard to talk about a surprise here, because previously the CRM software vendor chose Microsoft Azure as the cloud provider.
Read
MS Teams – a creature that lives. Interview with Jarosław Szybiński (TTMS)
What would you improve in Microsoft Teams? – Working with Teams and Office 365 is a bit like a paranoid dream. Microsoft continues to add, improve and change features. Sometimes I don’t know, if there was something missing yesterday or if it’s just my imagination – says Jarosław Szybiński, Business Development Manager at Transition Technologies […]
Read
NIS2 Cybersecurity in Pharma Requirements, Obligations,and Implementation in 2026
NIS2 cybersecurity in pharma is an operational resilience requirement, not a stand-alone IT project. A cyber incident can stop a filling line, isolate a laboratory, interrupt a cold chain, corrupt a clinical dataset or make a validated system unavailable. Each outcome can affect product quality, patient safety and continuity of supply. Directive (EU) 2022/2555, known as NIS2, creates a common EU baseline for cybersecurity risk management, management oversight and significant-incident reporting. The legal duty is implemented through national law. A company must therefore read the Directive together with the rules, thresholds, registration procedures and competent-authority guidance in every Member State where it falls within scope. This guide converts the legal baseline into actions and evidence for pharmaceutical manufacturers, biotechnology companies, medicinal-product R&D organisations, contract manufacturing organisations (CMOs), contract research organisations (CROs) and their critical suppliers. It also explains where NIS2 must be aligned with GxP, Computerized System Validation (CSV), Computer Software Assurance (CSA), GAMP 5 and existing quality-management processes. This article covers pharma-specific implementation. For the detailed evidence model, see the TTMS NIS2 compliance documentation and evidence checklist. 1. Why pharmaceutical operations are a priority cyber target under NIS2 NIS2 places the manufacture of basic pharmaceutical products and pharmaceutical preparations within the health sector in Annex I, alongside healthcare providers, EU reference laboratories and entities carrying out research and development of medicinal products. That classification reflects systemic impact: disruption can affect access to medicines and public-health response, not only one company’s balance sheet. The threat picture supports that treatment. ENISA reported that, among health-related incidents analysed for its 2024 threat landscape, 45% involved ransomware and 28% involved data breaches. A separate commercial dataset counted 4,198 ransomware cases exposed on dark-web leak sites across all sectors in the first half of 2025, 49% more than in the comparable 2024 dataset. The 4,198 figure is not pharma-specific, so it should not be presented as a count of attacks on pharmaceutical or biotechnology organisations. Pharma combines assets that create leverage for attackers: intellectual property, clinical and patient-related data, regulated production, scarce batches, time-sensitive logistics and a broad supplier network. The same identity platform, integration layer or remote-maintenance channel may connect corporate IT with ERP, MES, LIMS, ELN, EDC and operational technology (OT). An attacker does not need to compromise every system. Disrupting one shared dependency may be enough to stop release, testing or distribution. Treat the business impact as a chain. Map each critical product or service to facilities, processes, systems, data, utilities, people and third parties. Record the maximum tolerable outage and the quality consequences of data loss or delayed review. That service map becomes evidence for risk analysis, business continuity, recovery priorities and supply-chain decisions. 2. NIS2 in life sciences: scope, classification and legal status NIS2 expanded the EU cybersecurity baseline beyond the narrower NIS1 model. It applies, as a rule, to medium-sized and large entities of a type listed in Annex I or Annex II, subject to specific inclusions and exceptions. In life sciences, the legal analysis must start with what the entity actually does—not the brand description “pharma”, “biotech” or “healthcare”. Activities may include medicinal-product R&D, API or finished-product manufacture, device manufacture, clinical operations, distribution, marketing, digital services or combinations of them. A group can contain entities with different statuses. A CMO or CRO is not automatically in or out merely because of its label. The relevant activity, size, establishment, jurisdiction and any national designation must be documented. 2.1 From NIS1 to NIS2: what changed for health and pharma NIS2 widens sector coverage, standardises a minimum set of cybersecurity risk-management measures, sets a staged significant-incident reporting model and strengthens supervision and enforcement. It requires management bodies to approve risk-management measures, oversee implementation and receive training. It also requires Member States to maintain national cybersecurity strategies and incident-response structures. The result is a common baseline, not identical administration across the EU. Registration, thresholds, forms, competent authorities, language, audit expectations and sanctions are implemented nationally. In July 2026, the Commission referred Ireland, Spain, France and the Netherlands to the Court of Justice for failing to notify full transposition. Cross-border groups still need a jurisdiction register and local legal verification. Existing GMP and quality-management governance can provide a starting structure. Management review, change control, deviation management, CAPA, supplier qualification, training and periodic review already create owners and records. Extend those processes to cybersecurity; do not assume that GxP evidence automatically proves NIS2 compliance. 2.2 Essential or important entity? Classify before selecting controls Under Article 3, an Annex I entity that exceeds the ceiling for a medium-sized enterprise is generally an essential entity. Other medium-sized entities within Annex I or Annex II are generally important entities, unless a specific rule or national designation changes the result. Certain entity types are essential regardless of size. Micro and small enterprises are generally excluded, but Article 2 contains exceptions based on criticality and other factors. Pure distribution or marketing activity may fall outside the listed pharma categories when the entity performs no covered activity and is not designated on another basis. Conversely, an organisation conducting medicinal-product R&D can fall within Annex I even if it does not manufacture. Medical-device coverage also requires careful reading of the relevant Annex category; not every device business has the same classification. Create a signed scope memorandum for each legal entity. Include activities, NACE or equivalent classification, headcount and financial data, establishments, services, national rules, group dependencies and the reason for the conclusion. Record who approved it and when it must be reviewed. This memorandum is the first auditable artefact; a product brochure or a group-level assumption is not enough. 3. Four compliance pillars for pharmaceutical organisations Organise NIS2 around four connected pillars: risk management, significant-incident reporting, management accountability and supply-chain security. Each needs an owner, a procedure and operating evidence. 3.1 Article 21 risk management: ten minimum areas Article 21 requires appropriate and proportionate technical, operational and organisational measures based on an all-hazards approach. The ten minimum areas below should be mapped to services and risks, not treated as a generic tool-purchasing list. Article 21 area Pharma implementation focus Typical audit evidence 1. Risk analysis and information-system security policies Link product, patient and service impact to IT, OT and GxP systems Approved method, service map, risk register, treatment decisions 2. Incident handling Coordinate security, quality, privacy, legal, production and communications Incident plan, severity matrix, case records, after-action reports 3. Business continuity, backup, disaster recovery and crisis management Prioritise batch, laboratory, release and cold-chain dependencies BIA, RTO/RPO, recovery plans, restore tests, exercise reports 4. Supply-chain security Assess API, CMO, CRO, logistics, cloud and maintenance dependencies Supplier tiering, due diligence, contracts, monitoring, exit plans 5. Secure acquisition, development and maintenance, including vulnerability handling and disclosure Connect security changes to validated-state and change-control decisions Security requirements, threat models, vulnerability records, change packages 6. Assessment of control effectiveness Test design, coverage and operating results Control tests, metrics, internal audits, CAPA and closure evidence 7. Cyber hygiene and training Train by role, including engineers, laboratory staff and management Curricula, attendance, competence checks, phishing or exercise results 8. Cryptography and encryption Protect data and communications while managing keys and certificates Cryptography standard, key inventory, certificate monitoring, exceptions 9. HR security, access control and asset management Control joiners, movers, leavers, privileged access and system ownership Asset register, access reviews, PAM records, segregation-of-duties evidence 10. MFA or continuous authentication and secure communications Cover remote access, privileged actions and exposed services based on risk MFA coverage, exception register, secure-channel configuration and reviews Build requirements traceability between each NIS2 measure, the service risk, the control, the system owner and the evidence source. Existing GxP processes can carry part of the load. Vulnerability remediation can use change control; control testing can align with periodic review and CSA; security training can use the controlled learning system. The mapping must also expose gaps. A validated application with no tested recovery process remains a continuity risk. 3.2 Article 23 reporting: 24 hours, 72 hours and one month For a significant incident, Article 23 establishes staged reporting: an early warning without undue delay and within 24 hours after becoming aware; an incident notification without undue delay and within 72 hours; and a final report no later than one month after the incident notification. Intermediate or progress reports may also be required. If the incident is ongoing at the one-month point, a progress report replaces the final report and the final report follows within one month after handling ends. The clock starts from awareness, not from completion of a forensic investigation. Define who can declare awareness, who assesses significance, who contacts the national CSIRT or competent authority and who coordinates parallel duties under GDPR, sector rules, contracts and, where relevant, medical-device obligations. Preserve both the decision to report and a reasoned decision not to report. Real-time visibility across identity, network, endpoint, cloud, ERP, MES, LIMS, ELN, EDC and OT improves the chance of meeting the timetable. A central SIEM can support detection and chronology, but it does not make a legal significance assessment. Use a human-in-the-loop process with on-call authority, a current contact list, pre-approved templates and a decision log. In validated environments, deploy monitoring through approved change control. Passive OT monitoring, network telemetry and controlled log forwarding may reduce interference with production assets. Test the entire route in a tabletop exercise: alert, technical triage, quality impact, legal assessment, management escalation, authority submission and follow-up. 3.3 Article 20: management responsibility and board-level evidence Management bodies must approve the Article 21 measures, oversee implementation and can be held liable for infringements under national law. Members must follow training, and Member States must encourage regular training for employees. Evidence should show informed oversight, not a ceremonial annual presentation. Provide the board with decisions it can act on: top service risks, overdue high-risk treatments, control effectiveness, significant incidents, recovery-test failures, critical supplier exposure, material exceptions and required investment. Retain agendas, papers, minutes, approvals, challenge and follow-up. Record training content, attendance and an effectiveness check. The Directive also allows competent authorities, in specified circumstances concerning essential entities, to request temporary suspension of a certification or authorisation and a temporary prohibition on certain senior managers exercising managerial functions until deficiencies are remedied. This is a supervisory measure with conditions, not an automatic personal ban after every incident. Avoid overstating it as criminal liability. 3.4 Article 21(2)(d): API, CMO, CRO and logistics risk Map suppliers to the services and products they can affect. Include API and excipient suppliers, CMOs, CROs, testing laboratories, packaging, cold-chain logistics, cloud platforms, managed services, equipment vendors, remote maintenance and single-source technology dependencies. Tier suppliers using impact, access, substitutability, concentration and recovery time. Due diligence should test the evidence relevant to the service: control scope, incident history, privileged access, subcontractors, vulnerability handling, backup and recovery, secure development, geographic concentration and exit feasibility. A questionnaire is a declaration; a certificate has value only after its scope, exclusions and period are checked. Contracts should define minimum controls, incident-notification timing, cooperation, audit or assurance rights, vulnerability handling, subcontractor conditions, data return, continuity and exit. Contract language does not replace monitoring. Record reviews, adverse findings, risk acceptance, compensating controls, owners and expiry dates. 4. Pharma-specific cybersecurity challenges NIS2 does not solve by itself NIS2 states outcomes and minimum risk areas. It does not prescribe how to patch a validated MES, monitor a PLC in a clean manufacturing area or preserve ALCOA+ principles during a cyber response. These decisions require security, quality, engineering and regulatory roles to work from one risk record. 4.1 Secure validated systems without losing validated state A security patch or configuration change can affect the validated state of MES, LIMS, QMS, chromatography, environmental-monitoring or other GxP systems. Delaying every patch is unsafe; applying every patch without assessment is also unsafe. The control objective is a documented, risk-based decision. Connect vulnerability management to change control. Record asset and version, vulnerability severity, exploitability, patient or product impact, exposure, vendor support, proposed change, test scope, rollback, compensating controls and approval. Use GAMP 5 and CSV or CSA principles to scale assurance to the risk of the changed function. Re-test what can affect intended use, data integrity, electronic records, interfaces and critical calculations. Maintain validated state throughout the lifecycle. Periodic review should reconcile configuration, deviations, patches, access, backup, audit trails, incidents and supplier changes. Emergency changes need predefined authority and retrospective quality review. Evidence should make the sequence traceable from threat to decision, test, release and post-implementation monitoring. 4.2 Protect clinical-trial data, IP and patient-related information NIS2 covers entities carrying out R&D activities of medicinal products when the scope and size rules are met. Their risk model must protect availability, authenticity, integrity and confidentiality across protocol design, investigator sites, eCOA, EDC, safety systems, biostatistics, regulatory submissions and partner exchanges. Apply ALCOA+ data-integrity thinking: records should remain attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring and available. Cyber controls must protect the audit trail and the context required to interpret data. Detect bulk data exports, unusual privileged activity, manipulation and unauthorised interface changes. Test restoration of both data and metadata. Privacy belongs in a coordinated but distinct assessment. A single event can create a NIS2 significant-incident question and a GDPR personal-data-breach question with different tests, recipients and deadlines. Maintain one fact base and timeline, then run separate legal decision paths. 4.3 IT/OT convergence in manufacturing and clean areas OT assets often have long lifecycles, vendor constraints, deterministic communications and limited maintenance windows. Standard endpoint agents may be unsupported. A production pause can itself create quality and supply consequences. Treat OT as a distinct engineering risk domain connected to enterprise governance. Begin with passive discovery and verified ownership. Define zones and conduits, restrict remote access, separate safety and control functions from business networks, protect engineering workstations, monitor allowed communications and control removable media. Use compensating controls when patching is not feasible. Confirm that segmentation and fail-safe behaviour do not disrupt real-time control or environmental conditions. Every change should have cyber, automation and quality acceptance criteria. Test during approved windows, document rollback and retain configuration baselines. The evidence package should include current diagrams, firewall rules, remote-access reviews, alert handling, backup or configuration-restore tests and approved exceptions. 5. NIS2, GDPR, MDR and quality systems: one management model NIS2 protects the resilience and security of network and information systems. GDPR protects personal data and creates breach-notification duties. MDR and IVDR govern medical devices and include safety, quality and post-market obligations. GMP and GxP govern product quality and data integrity. One incident can activate several regimes, but the legal tests are not interchangeable. Build one management model with multiple compliance mappings. Use a common service catalogue, asset register, risk method, incident record, supplier register, training process, CAPA workflow and evidence index. Map each control to the applicable NIS2 article, national law, GDPR requirement, quality procedure and device obligation. This reduces duplicate evidence without collapsing distinct decisions. Create a regulatory decision matrix before an incident occurs. For each regime, record the trigger, decision owner, recipient, deadline, minimum content and rule for follow-up. Add contractual notifications and communications to investigators, insurers, partners and affected customers. During an incident, one coordination lead should maintain the verified facts, while qualified owners make the separate legal and quality decisions. This model reduces contradictory reporting without allowing the shortest deadline to erase the distinct tests applied by each regime. ISO/IEC 27001 can provide a useful information-security management structure; it does not by itself prove NIS2 scope, registration or national reporting compliance. ISO/IEC 42001 can support governance where AI is used in LIMS analytics, quality review or security operations, but AI controls still require validation, data-integrity assessment and human oversight appropriate to the use case. Design an integrated incident form with separate sections for service impact, product and patient impact, personal data, regulatory status, notification decisions and communications. The same verified timeline can support the CSIRT, data-protection authority, quality unit and management without creating contradictory versions. 6. Penalties and enforcement: the cost of non-compliance Article 34 requires Member States to provide maximum administrative fines for essential entities of at least EUR 10 million or at least 2% of worldwide annual turnover in the preceding financial year, whichever is higher. For important entities, the corresponding levels are at least EUR 7 million or 1.4%, whichever is higher. National law determines the applicable enforcement process and may set higher maximums or additional measures. Fines are only one exposure. A cyber incident can generate lost sales, scrapped batches, delayed trials, recovery costs, contractual claims, privacy consequences and loss of confidence. Merck reported that its 2017 network attack disrupted manufacturing, research and sales, reduced 2017 sales by approximately USD 260 million and generated USD 285 million of manufacturing and remediation expense net of stated insurance recoveries; residual backlog affected 2018 sales by approximately USD 150 million. Do not justify controls only by comparing programme cost with the statutory maximum. Prioritise by service impact, credible threat, control weakness and legal duty. The board should see both compliance exposure and the operational loss scenario for each critical product or service. 7. A 9-12 month NIS2 implementation roadmap for pharma A 9-12 month programme can organise remediation, but it is not a legal grace period. Organisations already subject to national implementing law must meet current duties while improving maturity. Sequence work around critical risk and approved change windows in validated environments. 7.1 Step 1: scope and gap analysis Confirm each legal entity’s status and jurisdiction. Inventory critical services and products, then map IT, OT, laboratory, clinical, data, facility, people and supplier dependencies. Assess the ten Article 21 areas and national obligations. The assessment should produce an approved scope memorandum, jurisdiction register, service and dependency map, asset baseline, gap report, risk-ranked remediation plan and evidence index. Escalate any unknown externally exposed asset or unsupported critical system immediately. 7.2 Step 2: governance and accountability Assign executive sponsorship, service owners, control owners and an incident-reporting authority. Define RACI across security, IT, OT, engineering, quality, privacy, legal, procurement, HR, communications and business continuity. At this stage, the organisation should have a governance charter, RACI, management reporting pack, risk-acceptance thresholds, training plan, CSIRT contact matrix and defined authority for isolating production or laboratory systems. 7.3 Step 3: technical and organisational controls Prioritise identity, privileged access, MFA, network segmentation, secure remote access, EDR where supported, passive OT monitoring, central logging, vulnerability management, protected backups and recovery. Connect each change to quality and validation procedures. Completion is evidenced by approved architectures, control requirements, implementation records, validation or assurance evidence, coverage metrics, an exception register and tested rollback. Measure the population covered, not only whether a tool was purchased. 7.4 Step 4: supplier verification and continuous monitoring Tier API, CMO, CRO, laboratory, logistics, cloud, software and maintenance suppliers. Run due diligence proportional to access and impact. Remediate contracts and establish monitoring triggers. The operational output is a maintained supplier register supported by a criticality model, evidence reviews, risk decisions, security clauses, incident contacts, a monitoring schedule, concentration analysis and exit plans. Reassess after a material change or incident. 7.5 Step 5: build and test incident response Create playbooks for ransomware, data exfiltration, validated-system compromise, OT disruption, supplier incident and loss of a critical cloud service. Include quality and regulatory decisions, not only technical containment. The response capability should be documented in an incident plan, 24/72-hour and final-report templates, a significance assessment, an evidence-preservation method and a tabletop report. Run the exercise with executives and on-call personnel. Track corrective actions to verified closure. 7.6 Step 6: document, audit and sustain Convert control operation into evidence by design. Automate controlled reports where practical, identify record owners and set retention based on national law, sector duties, investigation needs and risk. Review the programme after incidents, major changes and legal updates. The programme closes with a controlled policy set, evidence index, management minutes, training records, incident and supplier files, recovery-test results, effectiveness testing, an internal-audit report and a CAPA register. Independent review should confirm closure of high-risk findings. 8. Documented cyber incidents: practical NIS2 lessons Public incident reports rarely prove which internal control failed. Use them to test plausible scenarios, not to accuse an organisation of a control deficiency that has not been established. Merck’s 2017 attack demonstrates that enterprise malware can reach manufacturing, research, sales and fulfilment at the same time. The NIS2 lesson is to map shared dependencies, segment environments, protect recovery capabilities and quantify product-level continuity. Exercise the decision to isolate a plant system when isolation may interrupt production. The 2020 cyberattack on the European Medicines Agency unlawfully accessed documents related to COVID-19 medicines and vaccines. EMA reported that some leaked material, including correspondence, had been manipulated before publication. The lesson is broader than confidentiality: protect authenticity, integrity and provenance across regulator and partner exchanges, and prepare communications for manipulated or incomplete data. Cencora disclosed in February 2024 that data had been exfiltrated from its information systems and might contain personal information. It stated at the time that operations remained functional and that containment, investigation, law-enforcement engagement and external support had begun. The lesson is to maintain rapid cross-functional triage even when availability is not affected: exfiltration can still trigger NIS2, privacy, contractual and trust decisions. For each scenario, retain the alert timeline, affected services, evidence sources, quality assessment, reporting decision, management escalation and corrective actions. Link lessons to Article 21 controls and test whether the same evidence could support the 24-hour early warning. 9. Selecting expert support for NIS2 implementation A pharma NIS2 partner must combine cybersecurity, regulated quality and implementation capability. Ask for evidence that the team can classify scope, map services, design IT/OT controls, manage validated change, build CSV or CSA evidence, assess suppliers, run incident exercises and explain residual risk to management. Evaluate the delivery model. A one-time gap report does not sustain compliance. Managed services can operate monitoring, vulnerability triage, evidence collection and supplier review, but accountability remains with the regulated organisation and its management. Define ownership, escalation, service levels, evidence access and exit from the start. Request sample deliverables before selection: a redacted scope memorandum, an Article 21 traceability matrix, a validated change package, an OT risk assessment, a supplier finding and an executive incident exercise report. Check whether conclusions identify assumptions, evidence and residual risk. Confirm that security specialists can work with quality, automation and legal teams, and that records can be transferred into the organisation’s controlled repositories. The partner should leave the organisation with an operating process and usable evidence, not a slide deck that cannot be maintained. TTMS combines an ISO/IEC 27001 information-security management environment with pharmaceutical computerized-system validation services aligned to GAMP 5 and Annex 11. Its published quality offering covers CSV and CSA across the system lifecycle. In February 2026, TTMS reported becoming the first Polish company to obtain accredited ISO/IEC 42001 certification for its AI management system after an audit by TÜV Nord Poland. These credentials are relevant where cyber controls, validated systems and governed AI must remain auditable in one operating model. To arrange a scoping call focused on legal entities, regulated services, critical products, validated systems, OT dependencies and current evidence, contact TTMS. The first output should be a defensible scope and prioritised action plan—not a generic control catalogue. 10. Frequently asked questions about NIS2 cybersecurity in pharma Does NIS2 apply to every pharmaceutical company? No. Scope depends on activity, size, establishment, national law and designation. Manufacturing and medicinal-product R&D are listed; marketing or distribution alone may lead to a different result. Document the conclusion for each legal entity. Is every pharmaceutical manufacturer an essential entity? No. Annex I classification does not automatically make every manufacturer essential. Size thresholds, Article 3 rules, exceptions and national decisions determine whether an organisation is essential, important or outside scope. Group companies may reach different conclusions. What are the main NIS2 incident-reporting deadlines? For a significant incident, the Directive sets an early warning within 24 hours of awareness, an incident notification within 72 hours and a final report within one month. National procedures and parallel duties under GDPR or sector rules must also be checked. How do NIS2, GxP and Annex 11 interact in pharmaceutical environments? NIS2 governs cyber risk and resilience; GxP and Annex 11 govern product quality, data integrity and computerized systems. Use one risk and change-control model while preserving separate legal assessments and validation evidence for security changes. How should security patches be handled in validated GxP systems? Route the vulnerability through risk assessment and controlled change. Document exploitability, product or patient impact, test scope, rollback and compensating controls. Apply CSV or CSA assurance proportionate to the affected function and retain traceability from the vulnerability to approval and post-change review.
Read
LXP vs LMS: Which Platform Wins in 2026?
LMS and LXP platforms solve different learning challenges. An LMS is designed to manage, deliver, and track structured training, while an LXP focuses on personalized, learner-driven learning and continuous skill development. Many organizations don’t choose one over the other. Instead, they use both to support different learning objectives. Choosing between them can feel a bit like deciding between a library and a streaming service. One organizes learning in a structured way, while the other helps people discover relevant content based on their interests, goals, and previous activity. It’s a simple comparison, but it captures why the LMS vs LXP discussion continues to shape corporate learning strategies. From our experience working with enterprise learning programs, one of the most common misconceptions is that an LXP is simply a newer version of an LMS. In reality, the two platforms serve different purposes. Organizations that see the best learning outcomes typically treat them as complementary technologies, using each where it delivers the greatest value. Understanding those differences is essential before investing in a learning platform. The right choice depends not only on the features you need today but also on how your organization plans to develop skills, manage compliance training, and support continuous learning over time. 1. LXP vs LMS: Understanding the Core Difference Before You Choose Who actually drives the learning experience? With an LMS, the organization does. Administrators design structured courses, assign them to learners, and track completion. With an LXP, the learner takes ownership. The platform surfaces relevant content, suggests next steps, and encourages exploration. Think of an LMS as a formal curriculum and an LXP as a personalized learning feed. Neither is inherently superior. What matters is whether the platform fits your learning strategy, your workforce profile, and the outcomes you’re actually trying to drive. That distinction also shapes how your L&D team operates, how your IT infrastructure connects, and how your employees feel about learning at work. 2. What Is an LMS? Purpose, Features, and Best-Fit Use Cases A Learning Management System is the backbone of corporate training in most organizations. It centralizes, delivers, and tracks formal learning, particularly in environments where consistency and compliance aren’t optional. Onboarding new hires and certifying staff in regulated industries are two of its most common applications, and in both cases the LMS provides the structure that keeps programs running reliably at scale. 2.1 How an LMS Structures and Delivers Learning An LMS organizes content into predefined courses and learning paths. Learners receive assignments, complete modules in sequence, pass assessments, and receive certificates or completion records. Everyone in a given role or department ends up meeting the same standard. This works well when the goal is measurable competency. A new safety technician needs to complete specific modules before working on-site. A financial advisor must pass compliance training before advising clients. The LMS produces a clear, documented trail of who learned what and when, which is often a legal requirement rather than just an internal preference. 2.2 Core LMS Features That Drive Compliance and Administration A strong LMS is built around control, structure, and governance. It helps administrators track completion rates, assessment results, certification status, and mandatory training progress without digging through separate files or manual reports. It also supports role-based enrolment, automated reminders, and audit-ready documentation, which is why LMS platforms remain essential in regulated sectors such as healthcare, finance, manufacturing, and aviation. The problem starts when organizations expect an LMS to create the whole learning experience. Most LMS platforms are not designed to spark curiosity, recommend content based on individual goals, or make learning feel self-directed. They are excellent at answering the question: “Has this person completed the required training?” They are usually weaker at answering: “What should this person learn next to grow in their role?” That is the gap an LXP is designed to fill. 3. What Is an LXP? Purpose, Features, and Best-Fit Use Cases A Learning Experience Platform puts learners at the center. Rather than assigning fixed courses, an LXP pulls content from multiple sources, curates it based on individual preferences and goals, and surfaces what’s most relevant to each person. It ends up feeling more like a professional development hub than a training portal. 3.1 How an LXP Personalizes and Surfaces Learning Personalization in an LXP relies on AI and machine learning to analyze how each learner interacts with the platform: what topics they engage with, what skills they’ve listed, what their peers in similar roles explore. A software engineer who watches content on cloud architecture will see more relevant resources appear in their feed. A marketing manager who finishes a course on data analytics might get suggestions on audience segmentation or attribution modeling. That kind of timely relevance is what keeps learning from feeling static. The results are measurable. 88% of LXP users agree that an LXP provides a better learning experience than a traditional LMS, and 58% of HR leaders report improved training ROI through AI-curated learning journeys, which is the core capability LXPs are built around. 3.2 Core LXP Features That Drive Engagement and Discovery An LXP is strongest when learning is not limited to assigned courses. It helps employees discover relevant content, follow their interests, and learn from people inside the organization. Instead of relying only on a fixed training catalogue, an LXP can bring together content from internal knowledge bases, external providers, videos, podcasts, articles, and expert recommendations. Social learning features add another layer: employees can recommend resources, comment on materials, share achievements, and learn from colleagues who face similar challenges. This is where an LXP becomes more than a content library. With user-generated content, internal subject matter experts can contribute practical knowledge from real projects, customer cases, tools, or processes. From our experience, this often makes the platform more valuable than a polished but generic course catalogue because employees trust knowledge that comes from people who understand their daily work. The limitation is compliance. If every employee must complete a specific data privacy course by a regulatory deadline, an LXP alone is usually not enough. It may help people discover useful learning, but it does not give administrators the same level of tracking, audit readiness, or enforcement as an LMS. An LXP also needs the right learning culture. If employees see training only as a mandatory task, recommendation engines and social learning features will not create engagement by themselves. In that case, an LXP works best when supported by clear learning paths, manager involvement, and LMS-style structure. 4. LXP vs LMS: Side-by-Side Comparison When comparing LMS and LXP platforms directly, four dimensions reveal the most meaningful differences. In an LMS, administrators own the content entirely. They create, approve, and manage every piece of material learners encounter. An LXP opens that up to multiple contributors, including learners and internal experts, but doing that well requires a governance strategy to keep quality from slipping. Control also works differently in each system. Administrators in an LMS define learning paths, set deadlines, and decide what’s available to whom. In an LXP, learners build their own playlists and search topics that interest them, finding their own way through available content. On reporting, LMS platforms generate detailed audit logs and the documentation compliance officers need during inspections. LXP analytics focus on engagement, content popularity, and skill progression. That data is genuinely useful for L&D strategy, but it doesn’t replace compliance-grade reporting. Integration priorities differ too. An LMS typically connects with HRIS systems, SSO providers, and payroll platforms. An LXP tends to offer broader connectivity with external content libraries, collaboration tools, and skills databases, increasingly linking learning activity to performance management and career development. 5. How to Choose Between an LXP and LMS for Your Organization There’s no universal answer. The right choice depends on your workforce, your industry, your culture, and what you’re ultimately trying to achieve. In our experience helping organizations across healthcare, financial services, and technology evaluate platforms, the compliance question almost always comes first. Everything else tends to follow from there. An LMS is the right fit when compliance, standardization, and accountability are the primary goals. Healthcare providers certifying staff on patient safety protocols, financial institutions managing mandatory regulatory training, and any organization where incomplete training carries legal or operational consequences should build their learning infrastructure around a well-built LMS. An LXP suits organizations that want to build a learning culture rather than simply manage a training program. Companies in technology, creative industries, and professional services often find their workforce learns best through discovery, peer recommendation, and self-directed exploration. An LXP also works well for organizations trying to retain high performers by investing visibly in their career development. 5.1 When You Need Both: The Hybrid Approach 70% of new enterprise learning contracts now specify an LXP component, which reflects how commonly organizations are choosing to run both platforms rather than picking one. The two serve genuinely different purposes, and combining them creates a more complete learning setup than either alone. In a hybrid model, the LMS handles mandatory and compliance-driven training with the rigor and documentation that requires. The LXP sits alongside it, giving employees space to explore voluntary learning, develop skills beyond their current role, and engage with content from diverse sources. A practical example: a 1,500-person financial services organization arrived at a hybrid approach after realizing their compliance certification was well-managed in an LMS, but their technology and operations teams had no structured path for continuous upskilling. By integrating an LXP alongside the existing LMS and connecting both to a shared skills framework, they could enforce regulatory deadlines through the LMS while giving employees a self-directed track for career development. The L&D team gained a unified view of both mandatory completions and voluntary engagement, which made it possible to have more informed conversations about skill gaps at the team level. This integrated approach works particularly well in mid-to-large organizations carrying both compliance responsibilities and genuine ambitions around building a stronger learning culture. 6. How AI Is Reshaping LXP and LMS Platforms in 2026 AI is no longer a future feature in learning platforms. It’s already changing how both LMS and LXP systems work. In LXP systems, AI drives the core personalization engine, making content recommendations sharper and more contextually relevant as the system learns more about each user. In LMS platforms, AI is changing the administrative side: automated tagging reduces manual cataloging work, adaptive assessments adjust difficulty based on performance, and predictive analytics can flag learners at risk of missing compliance deadlines before those problems escalate. At TTMS, we help organizations work through this shift in practice. That means evaluating existing learning infrastructure, identifying where AI adds genuine value, and integrating both platforms into a broader IT setup. The most common mistake we see is organizations deploying an LXP without a minimum content governance framework in place first. Without that structure, user-generated content can erode platform trust quickly, and the self-directed learning culture the LXP was meant to build never really takes hold. 7. The Verdict: Which Platform Wins in 2026? Neither platform is the clear winner, and that is the most practical answer. An LMS is still the stronger choice for structured, compliance-driven training, especially in regulated industries where tracking, reporting, and certification management are non-negotiable. An LXP solves a different problem. It supports discovery, personalization, and continuous skill development in ways a traditional LMS was not designed to deliver. The important shift heading into 2026 is that the line between LMS and LXP platforms is becoming less rigid. AI is making LMS systems more adaptive, while LXP platforms are adding more structure around learning paths, reporting, and compliance support. Vendors are also building tighter integrations and, in some cases, offering combined environments that bring both approaches together. For most organizations, the right decision starts with clarity. Define the learning outcomes you need to achieve, understand what keeps your employees engaged, and assess your compliance requirements honestly. Then choose the platform, or combination of platforms, that matches those realities. The best learning platform is not the newest one. It is the one that fits the work your organization actually needs learning to support. If your organization needs… Choose Why? Mandatory training and regulatory compliance LMS Provides structured training management, certification tracking, reporting, and audit-ready documentation. Employee onboarding LMS Delivers standardized learning paths and ensures every new employee completes the required training. Continuous employee upskilling LXP Recommends personalized learning content based on individual skills, interests, and career goals. Building a learning culture LXP Encourages self-directed learning, knowledge sharing, and ongoing professional development. Compliance training in regulated industries LMS Offers robust reporting, certification management, and compliance monitoring. Career development and skills growth LXP Helps employees develop new capabilities through personalized recommendations and learning journeys. Leveraging internal expert knowledge LXP Makes it easy for subject matter experts to create and share valuable organizational knowledge. Managing both compliance and continuous learning LMS + LXP Combining both platforms provides structured compliance management while supporting personalized employee development. FAQ What is the difference between an LMS and an LXP? An LMS (Learning Management System) is designed to deliver, manage, and track structured training programs. It is commonly used for onboarding, compliance training, certifications, and mandatory learning. An LXP (Learning Experience Platform) focuses on personalized, learner-driven development. It recommends relevant content based on each employee’s skills, interests, and learning goals, helping support continuous learning beyond required courses. When should an organization choose an LMS? An LMS is the right choice when training must be standardized, assigned, and documented. It is particularly valuable for organizations operating in regulated industries where compliance, certifications, reporting, and audit-ready records are essential. Healthcare, financial services, manufacturing, and aviation are common examples. When is an LXP a better option? An LXP is best suited for organizations that want to encourage continuous learning and employee development. It works particularly well when employees are expected to build new skills independently, access learning from multiple sources, and receive personalized recommendations based on their interests and career goals. Can an LMS and an LXP work together? Yes. Many organizations use both platforms as part of the same learning ecosystem. The LMS manages mandatory training, compliance, and certifications, while the LXP supports self-directed learning, knowledge sharing, and continuous skills development. Together, they provide a more complete learning experience than either platform alone. Can an LXP replace an LMS? In most cases, no. While an LXP offers a better experience for personalized learning, it typically lacks the governance, reporting, certification management, and compliance capabilities required for mandatory corporate training. Organizations with regulatory obligations usually continue to rely on an LMS while adding an LXP to support employee development. How is AI changing LMS and LXP platforms? Artificial intelligence enhances both platforms in different ways. In LMS platforms, AI automates tasks such as content tagging, adaptive assessments, reporting, and predictive analytics. In LXP platforms, AI improves personalization by recommending learning content based on each employee’s role, behavior, interests, and skills. The greatest value comes from combining AI with high-quality, well-governed learning content. Which platform is better for compliance training? An LMS is the better choice for compliance training because it provides structured learning paths, completion tracking, certification management, automated reminders, and audit-ready reporting. These capabilities help organizations demonstrate compliance with internal policies and external regulations. How do you choose the right learning platform? The right choice depends on your organization’s goals. If your priority is regulatory compliance and standardized training, an LMS is usually the best option. If your goal is to build a culture of continuous learning and personalized employee development, an LXP may be a better fit. Many organizations achieve the best results by combining both platforms to support different learning objectives.
ReadRecommended articles
The world’s largest corporations have trusted us
We hereby declare that Transition Technologies MS provides IT services on time, with high quality and in accordance with the signed agreement. We recommend TTMS as a trustworthy and reliable provider of Salesforce IT services.
TTMS has really helped us thorough the years in the field of configuration and management of protection relays with the use of various technologies. I do confirm, that the services provided by TTMS are implemented in a timely manner, in accordance with the agreement and duly.
Ready to take your business to the next level?
Let’s talk about how TTMS can help.
Monika Radomska
Sales Manager